Research Grade Proteins Market Share, Size, Trends, Industry Analysis Report, By Product (Cytokines & Growth Factors, Antibodies, Immune checkpoint proteins, Virus Antigen, Enzymes, Others), By Host Cell (Mammalian Cells, Bacterial Cells, Others), By End-

Research Grade Proteins Market Share, Size, Trends, Industry Analysis Report, By Product (Cytokines & Growth Factors, Antibodies, Immune checkpoint proteins, Virus Antigen, Enzymes, Others), By Host Cell (Mammalian Cells, Bacterial Cells, Others), By End-use, By Region, And Segment Forecasts, 2024 - 2032

The global research grade proteins market size is expected to reach USD 3.53 billion by 2032, according to a new study by Polaris Market Research. The report “Research Grade Proteins Market Share, Size, Trends, Industry Analysis Report, By Product (Cytokines & Growth Factors, Antibodies, Immune checkpoint proteins, Virus Antigen, Enzymes, Others), By Host Cell (Mammalian Cells, Bacterial Cells, Others), By End-use, By Region, And Segment Forecasts, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Increasing investments in research and development in the field of cancer research, along with a rising demand for personalized medicines, are expected to be significant factors contributing to market growth. Additionally, government investments in various countries to support clinical studies are projected to drive market expansion. Furthermore, the biotechnology industry's ongoing advancements in developing nations are playing a crucial role in propelling market growth throughout the forecast period.

The market experienced a positive impact from the COVID-19 pandemic, driven by increased research efforts in vaccine, diagnostic, and therapeutic development. Regulatory authorities streamlined approval processes, leading to heightened demand for contract manufacturing services. While mRNA vaccines garnered attention, various recombinant protein vaccine alternatives were also under evaluation, contributing to the market's growth. For instance, In July 2022, Novavax, Inc. obtained expanded conditional marketing authorization for its Nuvaxovid recombinant protein-based COVID-19 vaccine in the EU. The pandemic underscored the necessity for adaptable biologics manufacturing capabilities, expected to enhance competition and drive market growth in the coming years.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/research-grade-proteins-market/request-for-sample

Numerous regions have established biobanks through cohort programs, offering researchers high-quality samples to advance treatment methods. This is likely to lead to a heightened emphasis on discovering biomarkers for diverse conditions. Consequently, initiatives and governmental investments in research endeavors to strengthen healthcare infrastructure are anticipated to broaden the applications of research-grade proteins, fostering market expansion.

Producing proteins is a time-intensive task, demanding meticulous maintenance of operating conditions throughout. Despite the soaring demand for these recombinant products, regulatory support is advancing relatively slowly. Typically, research-grade proteins are created through a host or an expression system. In this method, the gene specific to the desired product undergoes transfection, bacterial transformation, or viral transduction stages. This intricate process often results in the over-expression of unintended regions and consumes additional time. Hence, the absence of precise guidelines and regulations for recombinant technology stands as a significant obstacle to the thriving market of research-grade proteins.

Research Grade Proteins Market Report Highlights

Cytokines held the largest share, owing to its rising need in clinical studies, drug discovery & development

Mammalian cells segment dominated the market, primarily due to similar genetic make-up as humans, driving its usage in vaccines & monoclonal antibodies

Pharmaceutical segment held the largest share, owing to rise in research activities for drug development & personalized medicines

North America garnered the largest share, owing to presence of key players in the region, and robust medical infrastructure

The key market players include Thermo Fisher Scientific, Abcam, Miltenyi Biotec, GenScript, Bio-Techne, Proteintech Group, and New England Biolabs

Polaris Market Research has segmented the research grade proteins market report based on product, host cell, end use, and region:

Research Grade Proteins, Product Type Outlook (Revenue - USD Billion, 2019 - 2032)

Cytokines & Growth Factors

• Interferons (IFNs)
• Interleukins (ILs)
• Others

Antibodies

Immune Checkpoint Proteins

Virus Antigens

Enzymes

• Kinases
• Metabolic Enzymes
• Others

Recombinant Regulatory Proteins

Hormones

Others

Research Grade Proteins, Host Cell Outlook (Revenue - USD Billion, 2019 - 2032)

Mammalian Cells

Bacterial Cells

Fungi & Yeast

Insect Cells

Others

Research Grade Proteins, End Use Outlook (Revenue - USD Billion, 2019 - 2032)

Pharmaceutical & Biotechnology Companies

Academic & Research Institute

Others

Research Grade Proteins, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America

• U.S.
• Canada

Europe

• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands

Asia Pacific

• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia

Latin America

• Argentina
• Brazil
• Mexico

Middle East & Africa

• UAE
• Saudi Arabia
• Israel
• South Africa